Maggie L. DiNome, MD
Surgical Oncologist
My Locations
About Me
I am truly honored to provide care for patients with breast cancer and high-risk breast disease. I recognize that I enter patients’ lives at one of their most vulnerable moments. It is my goal to make sure that all patients feel cared for and confident that I will work hard for them and use the most advanced surgical techniques to treat their disease. Also, I like to focus on the aesthetic outcome of breast surgery while treating disease. I am proud to be part of Duke Health where I know patients receive high-quality cancer care, as well as access to the resources and support that help patients during their treatment.
- Professor of Surgery, Surgical Oncology 2022
- Chief, Section of Breast Surgery, Surgical Oncology 2022
- Member of the Duke Cancer Institute, Duke Cancer Institute 2022
Call for an Appointment
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
In the News
Loading
Loading
Loading
Clinical Focus and Research
My primary research focuses on the epigenetics of breast cancer. Epigenetics means “outside the gene” and reflects changes that occur during one’s lifetime that can impact the development and progression of breast cancer. I think of epigenetic modifications as light switches: they turn lights on and off. Genetic mutations are like light bulbs: if broken, lights will not turn on. Epigenetic changes are reversible, and therefore can be potential targets for therapy. It’s an exciting field.
-
Tailored Axillary Surgery in Node-Positive Breast CancerIRB# PRO00114419 , NCT# NCT03513614
- Single Cell and Spatial Analysis of Lethal Breast Cancers awarded by Department of Defense 2024 - 2028
- Wang, Ton, Drew Neish, Samantha M. Thomas, Astrid Botty van den Bruele, Laura H. Rosenberger, Akiko Chiba, Kendra J. Modell Parrish, et al. “Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.” JCO Clin Cancer Inform 9 (March 2025): e2400186. https://doi.org/10.1200/CCI-24-00186.
- Wang, Ton, Tyler Jones, Samantha M. Thomas, Astrid Botty Van den Bruele, Laura H. Rosenberger, Akiko Chiba, Kendra J Modell Parrish, et al. “Trends in Axillary Lymph Node Dissection After Mastectomy Among Patients With Limited Nodal Burden.” JAMA Netw Open 8, no. 2 (February 3, 2025): e2459692. https://doi.org/10.1001/jamanetworkopen.2024.59692.
- Record, Sydney M., Samantha M. Thomas, Juliet Dalton, Astrid Botty van den Bruele, Akiko Chiba, Gayle DiLalla, Maggie L. DiNome, et al. “Triple-Negative Breast Cancer in Older Patients: Does SLNB Guide Therapy?” Ann Surg Oncol 31, no. 13 (December 2024): 8802–12. https://doi.org/10.1245/s10434-024-16106-x.
- Limberg, Jessica N., Tyler Jones, Samantha M. Thomas, Koumani W. Ntowe, Juliet C. Dalton, Astrid Botty van den Bruele, Ton Wang, et al. “Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy.” In Ann Surg Oncol, 31:8813–20, 2024. https://doi.org/10.1245/s10434-024-16143-6.
- Parrish, Kendra M., Samantha M. Thomas, Sara B. Cartwright, Astrid Botty van den Bruele, Rebecca Zasloff, Gayle A. DiLalla, Maggie L. DiNome, et al. “Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study.” In Ann Surg Oncol, 31:8057–67, 2024. https://doi.org/10.1245/s10434-024-16026-w.
- Zasloff, Rebecca, Samantha Thomas, Kendra Parrish, Astrid Botty van de Bruele, Gayle DiLalla, Maggie DiNome, Laura Rosenberger, et al. “Abstract PO1-10-01: Racial/Ethnic Disparities in Rates of Pathological Complete Response and Survival in Patients with Inflammatory Breast Cancer.” In Cancer Research, Vol. 84. American Association for Cancer Research (AACR), 2024. https://doi.org/10.1158/1538-7445.sabcs23-po1-10-01.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.